Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79944.780.1305%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Dare Bioscience Inc

DARENASDAQ
Trade with Public
Trade with Public
$0.7210
0.00791.11%
At close: Sep 4, 5:00 PM EST
$0.7200
-0.001-0.14%
After Hours: Sep 4, 9:07 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Dare Bioscience Analyst Price Targets

Wall Street analyst price targets and consensus rating for Dare Bioscience (DARE).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

4Buy
Consensus RatingBuy# Analysts4Avg. Consensus PT$9Upside to Avg. PT+1150.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Dec 2, 2025HC Wainwright & Co.Douglas TsaoMaintainedBuy$12
Sep 4, 2025Maxim GroupCaroline PalomequeUpgradeHold→Buy$8
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.
Benzinga Newsdesk

This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Avi Kapoor

PRO
Maxim Group Upgrades Dare Bioscience to Buy, Announces $8 Price Target

Maxim Group analyst Caroline Palomeque upgrades Dare Bioscience (NASDAQ:DARE) from Hold to Buy and announces $8 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved